Gravlee G P, Ramsey F M, Roy R C, Angert K C, Rogers A T, Pauca A L
Department of Anesthesia, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, North Carolina.
Anesth Analg. 1988 Jan;67(1):39-47.
High-dose narcotic anesthetic inductions usually avoid circulatory depression better than do other techniques; however, the selection of a narcotic and neuromuscular blocker influences subsequent hemodynamic responses. One hundred-one patients having aortocoronary bypass graft (CABG) surgery were investigated using four combinations of a narcotic and neuromuscular blocker: group FP (fentanyl 50 micrograms/kg, pancuronium 100 micrograms/kg); group FV (fentanyl 50 micrograms/kg, vecuronium 80 micrograms/kg); group SP (sufentanil 10 micrograms/kg, pancuronium 100 micrograms/kg); and group SV (sufentanil 10 micrograms/kg, vecuronium 80 micrograms/kg), each combination being administered over 2 minutes. Hemodynamic functions were then monitored for 10 minutes before tracheal intubation. Significant changes included increases in heart rate in the groups receiving pancuronium and decreases in those receiving vecuronium. In all groups mean arterial pressure initially decreased; systemic vascular resistance index decreased significantly in all groups except SV. Cardiac index decreased significantly only in group SV. Circulatory depression requiring treatment with vasopressor or anticholinergic drugs was more common in patients given vecuronium. Cardiac arrhythmia occurred most often in group SP; only in group FP were there no arrhythmias, ischemic changes, or hemodynamic disturbances requiring intervention. Time to onset of neuromuscular blockade did not differ among the four groups, but transient chest wall rigidity occurred significantly more often with sufentanil than with fentanyl. Overall, the fentanyl/pancuronium combination afforded the greatest hemodynamic stability, whereas the sufentanil/vecuronium combination proved least satisfactory because of bradycardia and hypotension, requiring treatment in 35% of group SV patients.(ABSTRACT TRUNCATED AT 250 WORDS)
大剂量麻醉性诱导剂通常比其他技术更能有效避免循环抑制;然而,麻醉剂和神经肌肉阻滞剂的选择会影响随后的血流动力学反应。对101例行主动脉冠状动脉搭桥术(CABG)的患者使用四种麻醉剂和神经肌肉阻滞剂组合进行研究:FP组(芬太尼50微克/千克,潘库溴铵100微克/千克);FV组(芬太尼50微克/千克,维库溴铵80微克/千克);SP组(舒芬太尼10微克/千克,潘库溴铵100微克/千克);SV组(舒芬太尼10微克/千克,维库溴铵80微克/千克),每组组合在2分钟内给药。然后在气管插管前监测血流动力学功能10分钟。显著变化包括接受潘库溴铵的组心率增加,接受维库溴铵的组心率降低。所有组的平均动脉压最初均下降;除SV组外,所有组的全身血管阻力指数均显著下降。仅SV组的心指数显著下降。使用维库溴铵的患者中,需要用血管加压药或抗胆碱能药物治疗的循环抑制更为常见。心律失常最常发生在SP组;只有FP组没有需要干预的心律失常、缺血性改变或血流动力学紊乱。四组之间神经肌肉阻滞的起效时间没有差异,但舒芬太尼组短暂性胸壁强直的发生率明显高于芬太尼组。总体而言,芬太尼/潘库溴铵组合提供了最大的血流动力学稳定性,而舒芬太尼/维库溴铵组合因心动过缓和低血压而被证明最不理想,SV组35%的患者需要治疗。(摘要截选至250字)